Remedy publishes the financial statements release, two business reviews and the half-year review according to the disclosed annual schedule.
Event Date
Silent period and closed window 12.1.–12.2.2021
Financial statements release 2020 12.2.2021
Annual report, financial statements and Board of Directors’ report for 2020 Week 12 / 2021
Silent period and closed window 12.4.–12.5.2021
Annual General Meeting 2021 14.4.2021
Business review 1–3/2021 12.5.2021
Silent period and closed window 14.7.–13.8.2021
Half-year review 1–6/2021 13.8.2021
Silent period and closed window 13.10.–12.11.2021
Business review 1–9/2021 12.11.2021

Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.

During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.